Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 11/20 | 0.64 |
| ▸ | PKM | P14618 | 1/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.64 |
| ▸ | F13A1 | P00488 | 5/20 | 0.58 |
| ▸ | TGM1 | P22735 | 5/20 | 0.58 |
| ▸ | PRMT1 | Q99873 | 3/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | TGM3 | Q08188 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | SETD7 | Q8WTS6 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.52 |
| ▸ | MPO | P05164 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | HTR6 | P50406 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6481884 | 0.88 | TGM2 (0.66) | TGM2PKMF13A1TGM1LMNA | |
| SCHEMBL7785803 | 0.88 | TGM2 (0.66) | TGM2PKMF13A1TGM1LMNA | |
| SCHEMBL29054310 | 0.88 | TGM2 (0.66) | TGM2PKMF13A1TGM1LMNA | |
| SCHEMBL7894169 | 0.85 | TGM2 (0.66) | TGM2F13A1TGM1PRMT1LMNA | |
| SCHEMBL19457348 | 0.84 | TGM2 (0.77) | TGM2PKMF13A1TGM1LMNA | |
| SCHEMBL20885056 | 0.83 | TGM2 (0.63) | TGM2PKMCYP2C19F13A1TGM1 | |
| SCHEMBL20469814 | 0.83 | TGM2 (0.59) | TGM2PKMF13A1TGM1LMNA | |
| SCHEMBL17327893 | 0.83 | TGM2 (0.69) | TGM2F13A1TGM1LMNATGM3 | |
| SCHEMBL202328 | 0.81 | TGM2 (0.70) | TGM2F13A1TGM1LMNATGM3 | |
| Acetic Acid SCHEMBL11194307 | 0.81 | TGM2 (0.62) | TGM2PKMCYP2C19F13A1TGM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11111320-B2 | Addition-fragmentation oligomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2021-09-07 | — | — | US | disclosed |
| CN-107406723-B | Addition-fragmentation oligomers | 3M创新有限公司 | 2021-05-07 | — | — | CN | disclosed |
| EP-2675783-B1 | ADDITION-FRAGMENTATION AGENTS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-04-22 | — | — | EP | disclosed |
| EP-3259323-B1 | ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-02-26 | — | — | EP | disclosed |
| US-20200031961-A1 | ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-01-30 | — | — | US | disclosed |
| US-10479848-B2 | Addition-fragmentation oligomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-11-19 | — | — | US | disclosed |
| US-10370322-B2 | Addition-fragmentation agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-08-06 | — | — | US | disclosed |
| EP-3502092-A1 | ADDITION-FRAGMENTATION AGENTS | 3M Innovative Properties Company (US) | 2019-06-26 | — | — | EP | disclosed |
| EP-2931756-B1 | ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES CO (US) | 2018-08-08 | — | — | EP | disclosed |
| EP-3058014-B1 | ALLYL DISULFIDE-CONTAINING ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES CO (US) | 2018-06-20 | — | — | EP | disclosed |
| WO-2003015720-A1 | HARDENABLE SELF-SUPPORTING STRUCTURES AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-02-27 | — | — | WO | disclosed |
| WO-2002102909-A1 | REACTIVE OLIGOMERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2002-12-27 | — | — | WO | disclosed |
| US-20020132927-A1 | Pressure sensitive adhesives possessing high load bearing capability | 3M INNOVATIVE PROPERTIES COMPANY | 2002-09-19 | — | — | US | disclosed |
| US-6448337-B1 | CURABLE SYRUP COMPRISING DUAL POLYMERS CONTAINING PENDANT INTERREACTIVE GROUPS, FREE RADICAL POLYMERIZABLE SOLVENT MONOMER AND PHOTOINITIATOR; BALANCED ADHESIVE AND COHESIVE CHARACTERISTICS | 3M INNOVATIVE PROPERTIES COMPANY | 2002-09-10 | — | — | US | disclosed |
| EP-1230315-A1 | PRESSURE SENSITIVE ADHESIVES POSSESSING HIGH LOAD BEARING CAPABILITY | 3M Innovative Properties Company (US) | 2002-08-14 | — | — | EP | disclosed |
| WO-2002038694-A1 | PRESSURE SENSITIVE ADHESIVES POSSESSING HIGH LOAD BEARING CAPABILITY | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2002-05-16 | — | — | WO | disclosed |
| EP-0808348-B1 | CROSS-LINKABLE PRESSURE SENSITIVE ADHESIVE AND PROCESS FOR THE PRODUCTION OF AN ARTICLE COATED WITH A CROSSLINKED PRESSURE SENSITIVE ADHESIVE | MINNESOTA MINING & MFG (US) | 1999-05-06 | — | — | EP | disclosed |
| US-5741543-A | CONTAINING UNSATURATED MONOMERS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-04-21 | — | — | US | disclosed |
| EP-0808348-A1 | PROCESS FOR THE PRODUCTION OF AN ARTICLE COATED WITH A CROSSLINKED PRESSURE SENSITIVE ADHESIVE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-11-26 | — | — | EP | disclosed |
| WO-1996024644-A1 | PROCESS FOR THE PRODUCTION OF AN ARTICLE COATED WITH A CROSSLINKED PRESSURE SENSITIVE ADHESIVE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-08-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10479848-B2 | Addition-fragmentation oligomers | ECPAS, ITGA8, NBAS | TGM2 1638/4885PKM 4286/4885CYP2C19 4275/4885 |
| US-10370322-B2 | Addition-fragmentation agents | NR4A1, PARP14, MTX1 | TGM2 4329/4885PKM 3917/4885CYP2C19 4208/4885 |
| US-20200031961-A1 | ADDITION-FRAGMENTATION OLIGOMERS | ECPAS, ITGA8, NBAS | TGM2 1638/4885PKM 4286/4885CYP2C19 4275/4885 |
| US-11111320-B2 | Addition-fragmentation oligomers | ECPAS, ITGA8, NBAS | TGM2 1638/4885PKM 4286/4885CYP2C19 4275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.